![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, December 29, 2016 4:14:35 PM
First, Almost all the risk is now gone from the stock due to Novartis.
Second, The drug results Conatus has published to date are obviously encouraging to anyone who can read, however, can you imagine the depth to which Novartis dug into things before writing a $50mil check and pledging another $800mil to $1bil?
Third, the market cap TODAY is even less than it was a couple years ago before the results, before Novartis, before about anything.
Fourth, Think about some of the upcoming catalysts and PRs we are likely to see with respect to milestones and trigger payments.
This will not stay in the $5 price range for very long. I will venture this gets to about $8 by the end of next week, $20 by late Summer.
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM